Literature DB >> 28643157

Effect of variance ratio on ANOVA robustness: Might 1.5 be the limit?

María J Blanca1, Rafael Alarcón2, Jaume Arnau3, Roser Bono3, Rebecca Bendayan2,4.   

Abstract

Inconsistencies in the research findings on F-test robustness to variance heterogeneity could be related to the lack of a standard criterion to assess robustness or to the different measures used to quantify heterogeneity. In the present paper we use Monte Carlo simulation to systematically examine the Type I error rate of F-test under heterogeneity. One-way, balanced, and unbalanced designs with monotonic patterns of variance were considered. Variance ratio (VR) was used as a measure of heterogeneity (1.5, 1.6, 1.7, 1.8, 2, 3, 5, and 9), the coefficient of sample size variation as a measure of inequality between group sizes (0.16, 0.33, and 0.50), and the correlation between variance and group size as an indicator of the pairing between them (1, .50, 0, -.50, and -1). Overall, the results suggest that in terms of Type I error a VR above 1.5 may be established as a rule of thumb for considering a potential threat to F-test robustness under heterogeneity with unequal sample sizes.

Keywords:  ANOVA; F-test; Heterogeneity; Robustness; Variance ratio

Mesh:

Year:  2018        PMID: 28643157     DOI: 10.3758/s13428-017-0918-2

Source DB:  PubMed          Journal:  Behav Res Methods        ISSN: 1554-351X


  22 in total

1.  Autistic Adults Show Similar Performance and Sensitivity to Social Cues on a Visual Perspective Taking Task as Non-autistic Adults.

Authors:  Richard J O'Connor; Joshua L Plant; Kevin J Riggs
Journal:  J Autism Dev Disord       Date:  2022-02-19

2.  Caffeine-based flavor preference conditioning in the rat.

Authors:  Liyana Farabi; Simone Rehn; Robert A Boakes
Journal:  Learn Behav       Date:  2021-09-07       Impact factor: 1.986

3.  Individual Strategies of Response Organization in Multitasking Are Stable Even at Risk of High Between-Task Interference.

Authors:  Roman Reinert; Jovita Brüning
Journal:  Front Psychol       Date:  2022-04-06

4.  Assessing the Efficacy and Acceptability of a Web-Based Intervention for Resilience Among College Students: Pilot Randomized Controlled Trial.

Authors:  Angel Enrique Roig; Olwyn Mooney; Alicia Salamanca-Sanabria; Chi Tak Lee; Simon Farrell; Derek Richards
Journal:  JMIR Form Res       Date:  2020-11-11

5.  Cognitive processes that indirectly affect olfactory dysfunction in Parkinson's disease.

Authors:  Attakias T Mertens; Jonathan B Santo; Katerina Markopoulou; Bruce A Chase
Journal:  Clin Park Relat Disord       Date:  2019-07-20

6.  Electroretinography and Gene Expression Measures Implicate Phototransduction and Metabolic Shifts in Chick Myopia and Hyperopia Models.

Authors:  Nina Riddell; Melanie J Murphy; Sheila G Crewther
Journal:  Life (Basel)       Date:  2021-05-29

7.  Applying univariate vs. multivariate statistics to investigate therapeutic efficacy in (pre)clinical trials: A Monte Carlo simulation study on the example of a controlled preclinical neurotrauma trial.

Authors:  Hristo Todorov; Emily Searle-White; Susanne Gerber
Journal:  PLoS One       Date:  2020-03-26       Impact factor: 3.240

8.  Improving the practicality of using non-aversive handling methods to reduce background stress and anxiety in laboratory mice.

Authors:  Kelly Gouveia; Jane L Hurst
Journal:  Sci Rep       Date:  2019-12-30       Impact factor: 4.379

9.  Visual Evoked Potentials Used to Evaluate a Commercially Available Superabsorbent Polymer as a Cheap and Efficient Material for Preparation-Free Electrodes for Recording Electrical Potentials of the Human Visual Cortex.

Authors:  Torsten Straßer; Susanne Kramer; Melanie Kempf; Tobias Peters; Anne Kurtenbach; Eberhart Zrenner
Journal:  Sensors (Basel)       Date:  2019-11-09       Impact factor: 3.576

10.  Learning by task repetition enhances object individuation and memorization in the elderly.

Authors:  Chiara F Tagliabue; Sara Assecondi; Giulia Cristoforetti; Veronica Mazza
Journal:  Sci Rep       Date:  2020-11-17       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.